NLS Pharmaceutics Ltd. Warrant

NLSPW

...

NLSPW: NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Show NLSPW Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of NLSPW by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by NLSPW's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on NLSPW's company Twitter account

WallStreetBets

Number of mentions of NLSPW in WallStreetBets Daily Discussion

NLSPW News

Recent insights relating to NLSPW

CNBC Recommendations

Recent picks made for NLSPW stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NLSPW

Corporate Flights

Flights by private jets registered to NLSPW